Results 101 to 110 of about 138,819 (251)

RETRACTED ARTICLE: Serum melatonin levels and in a sample of Iranian patients with migraine

Scientific Reports
Migraine, a complex disorder, is characterized by recurrent headache episodes. The production of melatonin in the pineal gland, which is crucial for controlling circadian rhythms and sleep–wake cycles, is altered in various conditions, including ...
Mansoureh Togha, Morvarid Noormohammadi, Zeinab Ghorbani, Fariba Karimzadeh, S. Zahra Bathaie   +4 more
doaj   +1 more source

Three decades of research on the association between temporomandibular disorders and headache: A bibliometric analysis

Headache: The Journal of Head and Face Pain, EarlyView.
Abstract Objectives To perform a bibliometric analysis of the scientific literature published over the past 3 decades on the relationship between temporomandibular disorders (TMDs) and headache, examining scientific production, citation impact, and the conceptual structure and temporal evolution of research topics in this field. Background TMDs are the
Tatiana P. da Fonte, Maria L. M. Mesquita, Matheus Herreira‐Ferreira, Livia M. S. P. Fiamengui, Leonardo R. Bonjardim, Juliana Stuginski‐Barbosa, Paulo C. R. Conti   +6 more
wiley   +1 more source

Biochemical profiling and symptomatology of androgen deficiency in males with cluster headache: A prospective case–control study

Headache: The Journal of Head and Face Pain, EarlyView.
Abstract Objectives/Background Cluster headache (CH) has historically been considered a male‐dominated disorder, suggesting a role for androgens in its pathophysiology. We aimed to evaluate hormone profiles and symptoms of androgen deficiency in CH.
Willemijn C. Naber, Roemer B. Brandt, Mariël Leon Morales‐Grooters, Ronald van der Wal, Sjoerd A. A. van den Berg, Jelle J. Goeman, Antoinette Maassen van den Brink, Rolf Fronczek   +7 more
wiley   +1 more source

Topiramate for the prophylaxis of episodic migraine in adults

Cochrane Database of Systematic Reviews, 2013
Some antiepileptic drugs but not others are useful in clinical practice for the prophylaxis of migraine. This might be explained by the variety of actions of these drugs in the central nervous system. The present review is part of an update of a Cochrane review first published in 2004, and previously updated (conclusions not changed) in 2007.To ...
Mattias, Linde, Wim M, Mulleners, Edward P, Chronicle, Douglas C, McCrory   +3 more
openaire   +3 more sources

Family history of migraine in control and migraine frequency groups stratified by sex (A) and in episodic and chronic migraine groups stratified by sex and aura (B).

, 2020
In the male participants, the proportion of individuals with a family history of migraine was significantly lower in the chronic migraine group than in the episodic migraine group (26% vs. 49.5%; P < 0.05).
Hsuan-Te Chu (6178346), Chia-Lin Tsai (491834), Fu-Chi Yang (599007), Yu-Kai Lin (126745), Meei-Shyuan Lee (734558), Tsung-Han Ho (6476783), Jiunn-Tay Lee (491835), Guan-Yu Lin (315749), Yu-Wei Hsu (8407335), Chih-Sung Liang (762651)   +9 more
core   +1 more source

Feasibility of serum CGRP measurement as a biomarker of chronic migraine: a critical reappraisal

The Journal of Headache and Pain, 2018
Background Calcitonin gene-related peptide (CGRP) has been reported as elevated in chronic migraine. We aimed to validate the role of interictal serum CGRP concentration in peripheral blood samples as a biomarker of chronic migraine.
Mi Ji Lee, Sook-Yeon Lee, Soohyun Cho, Eun-Suk Kang, Chin-Sang Chung   +4 more
doaj   +1 more source

Early improvements in function with atogepant as assessed by the Activity Impairment in Migraine–Diary: Post hoc analyses of three randomized, phase 3 clinical trials of atogepant for the preventive treatment of migraine

Headache: The Journal of Head and Face Pain, EarlyView.
Abstract Objective Evaluate early functional improvements with the preventive migraine treatment atogepant using Activity Impairment in Migraine–Diary (AIM‐D) individual and activity limitation items, and complete improvement in AIM‐D Performance of Daily Activities (PDA) and Physical Impairment (PI) domain scores assessed weekly during the first 4 ...
Richard B. Lipton, Pranav Gandhi, Andreas R. Gantenbein, Brett Dabruzzo, Karen Carr, Jonathan Stokes, Molly Duan, Rashmi B. Halker Singh, Hsiangkuo Yuan, Dawn C. Buse   +9 more
wiley   +1 more source

Plasma amylin levels in migraine and after erenumab treatment: A REFORM study

Headache: The Journal of Head and Face Pain, EarlyView.
Plain Language Summary Researchers are searching for blood tests that can show what is happening in migraine and help predict who will benefit from preventive treatment, and blood amylin (a signaling molecule known to trigger migraine) has been shown to be elevated in people with chronic migraine.
Rogelio Domínguez‐Moreno, Tyla I. Alexander, William K. Karlsson, Haidar M. Al‐Khazali, Michael L. Garelja, Rune H. Christensen, Messoud Ashina, Debbie L. Hay, Håkan Ashina   +8 more
wiley   +1 more source

Microbiome Migraine study data

, 2022
Data for 'Altered gut microbiota in individuals with episodic and chronic ...
Min Kyung Chu (12185303)
core   +1 more source

Enduring phenotype of episodic status migrainosus in a prospectively identified patient

Cephalalgia Reports, 2018
Episodic status migrainosus is a previously described migraine variant where the exclusive phenotype is that of relapsing status migrainosus. The majority of cases have been reported based on retrospective chart review.
Jonathan H Smith
doaj   +1 more source